Muscle Damage Biomarkers in Congestion Weeks in English Premier League Soccer Players: A Prospective Study for Two Consecutive Seasons잉글랜드 프리미어 리그 축구 선수의 혼잡 주간 근육 손상 바이오마커: 연속 2시즌에 대한 전향적 연구Article Published on 2021-07-282022-09-10 Journal: International Journal of Environmental Research an [Category] SARS, 바이오마커, [키워드] age Biomarker body mass club collected conducted congestion COVID-19 pandemic creatine creatine kinase damage Department Dexa English enrolled exposure time fat fatigue GPS Height high speed running lean mass lockdown Medical Department Midfielder muscle muscle damage outcome performed position Prospective prospective cohort study Questionnaires room season Significance significantly increased soccer substitutions Week weight [DOI] 10.3390/ijerph18157960 PMC 바로가기 [Article Type] Article
Evaluation of the safety profile of COVID-19 vaccines: a rapid reviewResearch Article Published on 2021-07-282022-10-28 Journal: BMC Medicine [Category] COVID-19, SARS, [키워드] accounted adverse event age article candidate vaccine Candidates clinical trial clinical trials COVID-19 COVID-19 vaccine COVID-19 vaccines DNA vaccine eligible Evidence fatigue follow-up time Frequency group headache heterogeneity Human Inactivated vaccine incidence indicate Injection-site pain lack Local Meta-analysis Novel coronavirus diseases 2019 observational study outcome platform PMC pooled rate proportion protein subunit vaccine rapid process Reactions recipient Regulatory Reporting Research Result review RNA vaccine safety profile searched Serious Adverse Event severe acute respiratory syndrome coronavirus 2 significantly lower supplementary material Surveillance surveillance data systemic reaction systemic reactions treatment groups Vaccine virus-like particle vaccine was performed Web of Science [DOI] 10.1186/s12916-021-02059-5 PMC 바로가기 [Article Type] Research Article
Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-AnalysisSystematic Review Published on 2021-07-272022-10-28 Journal: Biomedicines [Category] COVID-19, [키워드] 95% CI abnormality Adults analyzed article average cause Chest Chest computed tomography collected cough COVID-19 Decreased Dyspnea Effect effective fatigue Follow-up functional functional capacity hospital discharge identify Impact impairment Infection information literature long-term effects Lung function management Meta-analysis outcome OVID Patient persistent symptoms post infection Post-infection Prevalence proportion Quality of life reported respiratory symptoms returned review symptom onset the patient was performed Web of Science [DOI] 10.3390/biomedicines9080900 PMC 바로가기 [Article Type] Systematic Review
Association Between Perceived Stress and Post-Traumatic Stress Disorder Among Medical Staff During the COVID-19 Epidemic in Wuhan CityPublic Health Published on 2021-07-262022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS, [키워드] addition association China city Compassion Compassion fatigue conducted COVID-19 COVID-19 outbreak fatigue frontline medical staff Health indicated Insomnia Insomnia severity Insomnia Severity Index Intervention lockdown mechanism medical staff mental health Perceived Perceived stress Perceived Stress Scale Post-traumatic stress disorder preventive measure PTSD scale severity supported Symptoms were used Wuhan [DOI] 10.3389/fpubh.2021.666460 PMC 바로가기 [Article Type] Public Health
Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort studyOriginal Article Published on 2021-07-232022-10-27 Journal: Brain Communications [Category] COVID-19, [키워드] affected analysed average BNT162b2 mRNA Care cause Characteristics clinical Clinical characteristics clinical feature complex coronavirus SARS-CoV-2 COVID-19 COVID-19 vaccination COVID-19 vaccine described fatigue forms Germany headache indicated Infectious disease information intensity International Classification of Headache Disorders medication moderate mRNA vaccine multicentre neurological novel coronavirus SARS-CoV-2 Observational cohort study occur Pain participant Participants Patient phenotype Prevent Primary outcome questionnaire reported resulting Side-effects Sociodemographic Spread suffered Symptom Symptoms Treatment United Arab Emirates university hospital vaccination vaccination against COVID-19 Vaccinations variable virus were recorded [DOI] 10.1093/braincomms/fcab169 PMC 바로가기 [Article Type] Original Article
Serum Metabolic Profile in Patients With Long-C ovid (PASC) Syndrome: Clinical ImplicationsMedicine Published on 2021-07-222022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] albumin alteration Anti-inflammatory anticoagulant therapy Blood clinical clinical conditions clinically Coagulation Concentration concomitant disease COVID-19 CRP D-dimer Dyspnea Elevation erythrocyte sedimentation rate evaluated fatigue ferritin hemoglobin hospital discharge implicated indicated Inflammation knowledge LDH Long-COVID-syndrome Long-term follow-up maintain marker metabolic metabolism molecular muscular PASC pathophysiology Patient patient symptom patients persistence profile Prophylactic Protein raise rehabilitation reported risk SARS-COV-2 infection SARS-CoV2 selected serum Seven Symptom syndrome thromboembolic disease virus infection weakness [DOI] 10.3389/fmed.2021.714426 PMC 바로가기 [Article Type] Medicine
Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial중등도 코로나바이러스 질병-2019(COVID-19) 치료에 사용되는 중국 전통 의학 Baidu Jieduan 과립: 공개, 무작위 대조 임상 시험을 위한 연구 프로토콜Study Protocol Published on 2021-07-222022-09-10 Journal: Trials [Category] SARS, 임상, 치료제, [키워드] 1:1 absence Adverse adverse events AEs Antibiotics antiviral medicine applied Baidu Baidu Jieduan granule baseline Chinese circulating clinical Clinical efficacy clinical evidence conducted control group Controlled clinical trial Controlled trial coronavirus coronavirus disease coughing COVID-19 develop Effect effective Efficacy and safety epidemic disease epidemic diseases evaluate event experimental group fatigue Fever Glucocorticoids Granule granules Health moderate Moderate COVID-19 multicentre Open-label outcome Patient patients with COVID-19 Primary outcome Randomized Randomized controlled trial Randomly receive registry resulting Standard therapy Study protocol supplementary material Support Symptom TCM theory Traditional Chinese medicine treating COVID-19 Treatment treatment group treatment initiation Trial twice a day use of antibiotics [DOI] 10.1186/s13063-021-05418-y PMC 바로가기 [Article Type] Study Protocol
A Clinical Monitoring Program of COVID-19 Outpatients: A Prospective Cohort StudyResearch Article Published on 2021-07-202022-10-31 Journal: The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale [Category] COVID-19, [키워드] Administered age C-reactive protein Characteristics clinical Clinical characteristics Clinical course clinical trial Comorbidity concerning contribute Coronavirus disease 2019 cough COVID-19 COVID-19 patient COVID-19 patients demographic demographics evaluated fatigue female Follow-up hemoglobin Hospitalization individual information laboratory data lymphocyte majority medication mild symptoms monitoring morbidity Mortality MOST myalgia Neutrophil-to-lymphocyte ratio no significant difference Observational cohort study onset of symptoms Patient patients pharmacotherapy Program Prospective recruited reduction required responsible Result severity significantly sore throat suffered Symptom symptom onset symptomatic Symptomatic patients Symptoms the patient variety was performed while White blood cell with COVID-19 [DOI] 10.1155/2021/6644570 PMC 바로가기 [Article Type] Research Article
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United StatesNeuroscience Published on 2021-07-192022-10-31 Journal: Frontiers in Aging Neuroscience [Category] COVID-19, [키워드] 95% CI activity adjusted age Analysis Anxiety average coded cognitive Community Community Dwellers conducted Contact covariate covariates COVID-19 COVID-19 negative COVID-19 positive subjects COVID-19 symptoms demographics Depression diagnosed Diagnosis disorder dysfunction eligible participant Factor fatigue female greater group Hispanic identify initial Laboratory testing logistic regression model Long-hauler male measure median Metrics multivariable logistic regression NIH no significant difference not differ occurred participant Participants past medical history platform positive Post-acute sequelae of SARS-CoV-2 infection predict Predictive predictor Prevalence Primary outcome Prolonged proportions psychological symptom Quantitative reported Research Result Sex significantly significantly higher stressors subjects subsequent Symptom the United State typical symptoms United State [DOI] 10.3389/fnagi.2021.690383 PMC 바로가기 [Article Type] Neuroscience
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey비활성화된 전체 비리온 SARS-CoV-2 백신(CoronaVac)의 효능 및 안전성: 터키에서 이중 맹검, 무작위, 위약 대조, 3상 시험의 중간 결과Clinical Trial Published on 2021-07-172022-09-12 Journal: Lancet (London, England) [Category] Fulltext, SARS, 임상, 진단, [키워드] 1:1 95% CI adverse event adverse events antibody test result bleeding disorders blood product clinical trial Cohort component CoronaVac COVID-19 criteria dose double-blind Efficacy Efficacy and safety enrolled exclusion fatality fatigue follow-up period Frequency health-care humoral hydroxide Immunoglobulin immunosuppressive inactivated individual intention-to-treat intention-to-treat population intramuscularly IQR Local median Negative PCR nine Older outcome Pain participant PCR-confirmed per 1000 person-years per protocol Phase 3 phase 3 trial Placebo placebo-controlled protocol provided randomised Randomly recruited Registered reported safety analysis safety profile SARS-CoV-2 screened second dose shown Steroids symptomatic the placebo group the vaccine therapy Tolerability trials Turkey Vaccine virion virus Volunteer whole-virion SARS-CoV-2 vaccine yielding [DOI] 10.1016/S0140-6736(21)01429-X PMC 바로가기 [Article Type] Clinical Trial